A Q1 2021 Earnings — Agilent Technologies, Inc. Revenue & Financial Results | Market Cap Arena

AAgilent Technologies, Inc.

$33B

Q1 2021 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$1.5B+14.1% YoY

Gross Profit

$838M54.1% margin

Operating Income

$328M21.2% margin

Net Income

$288M18.6% margin

EPS (Diluted)

$0.93

QoQ Revenue Growth

+4.4%

Cash Flow

Operating Cash Flow

$238M

Free Cash Flow

$197M

Stock-Based Comp.

$40M

Balance Sheet

Total Assets

$9.7B

Total Liabilities

$4.9B

Stockholders' Equity

$4.8B

Cash & Equivalents

$1.3B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.5B	$1.4B	+14.1%
Gross Profit	$838M	$723M	+15.9%
Operating Income	$328M	$215M	+52.6%
Net Income	$288M	$197M	+46.2%

Revenue Segments

Life Sciences and Applied Markets

$722M47%

Agilent CrossLab

$532M34%

Diagnostics and Genomics

$294M19%

Geographic Segments

Asia Pacific

$556M36%

Americas

$555M36%

Europe

$437M28%